enGene ENGNW

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

No daily data currently available, please try a different date range.

About

enGene (ENGNW) Business Model and Operations Summary
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

Key Insights

enGene (ENGNW) Core Market Data and Business Metrics
  • Latest Closing Price

    $0.8
  • Market Cap

    $36.20 Million
  • Average Trade Volume

    7,779.665 Shares
  • Total Outstanding Shares

    50.98 Million Shares
  • CEO

    Mr. Ronald H. W. Cooper
  • Total Employees

    57
  • IPO Date

    November 1, 2023
  • SIC Description

    Biological Products, (no Disgnostic Substances)
  • Primary Exchange

    NASDAQ
  • Headquarters

    4868 Rue Levy, Suite 220, Saint-laurent, A8, H4R 2P1

Earnings Reports

Expected vs. Actual Quarterly Earnings-Per-Share & Revenue

Short Volume

Daily short volume activity identifies short-term trading pressure and potential price volatility

Revenue Breakdown

Distribution of revenue across unique business segments & geographies

Historical Stock Splits

Execution DateSplit Amount

Historical Dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about ENGNW from trusted financial sources